Trandolapril News and Research

RSS
Researchers find current blood pressure recommendations for older patients

Researchers find current blood pressure recommendations for older patients

Chronic self-reported NSAID use associated with increased risk of adverse events in hypertensive patients with CAD

Chronic self-reported NSAID use associated with increased risk of adverse events in hypertensive patients with CAD

Data shows increased risk of heart attack, stroke for patients having high blood pressure

Data shows increased risk of heart attack, stroke for patients having high blood pressure

Aterovax presents results of its sPLA2 activity test in the PEACE trial

Aterovax presents results of its sPLA2 activity test in the PEACE trial

Some blood pressure drugs may help protect against dementia, study shows

Some blood pressure drugs may help protect against dementia, study shows

High blood pressure medication strategy proves effective in Hispanic women

High blood pressure medication strategy proves effective in Hispanic women

Lupin announces FDA approval of Trandolapril tablets

Lupin announces FDA approval of Trandolapril tablets

Hypertension drugs offer a double whammy

Hypertension drugs offer a double whammy

Trandolapril and verapamil reduce risk of developing diabetes in Hispanic patients

Trandolapril and verapamil reduce risk of developing diabetes in Hispanic patients

High blood pressure research advances efforts to tailor drugs to individual patients

High blood pressure research advances efforts to tailor drugs to individual patients

ACE inhibitors not needed for many heart disease patients

ACE inhibitors not needed for many heart disease patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.